ClinicalTrials.gg
CompletedNCT05468385Updated Dec 13, 2023

The Effects of taVNS on Inhibitory Control

An interventional study of Vagus nerve stimulation via tragus and Sham stimulation via earlobe in Healthy, sponsored by University of Electronic Science and Technology of China. Completed at 1 site in China. Open to participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-12-13.

Sponsored by University of Electronic Science and Technology of China · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
All
01

Study summary

The main aim of the study is to investigate whether the transcutaneous vagus nerve stimulation(tVNS) improves the ability of inhibitory control in an emotional Go-Nogo task.

Read the detailed description

A randomized, sham-controlled, between-subject design will be employed in this study. A total of 87 healthy subjects will receive either transcutaneous vagus nerve stimulation via tragus or sham stimulation via the earlobe in the left ear. Brain activity and behavioral data for an emotional Go-Nogo task will be recorded and saliva samples will be collected before, during, and after stimulation.

Some personal traits will be assessed using different kinds of questionnaires, such as the State-Trait Anxiety Inventory (STAI), Beck's Depression Inventory(BDI), Autism Spectrum Quotient (ASQ) et al.

02

Conditions studied

  • Healthy
03

In context

Lead sponsor

University of Electronic Science and Technology of China is the lead sponsor of 112 studies on the registry; 37 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy subjects without past or current psychiatric or neurological disorders

Exclusion criteria

Exclusion Criteria:

  • history of head injury;
  • pregnant, menstruating, taking oral contraceptives;
  • medical or psychiatric illness.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
90 participants (actual)

Study arms

  • Experimental
    Tragus stimulation

    Vagus nerve stimulation via tragus

    Device: Vagus nerve stimulation via tragus

  • Sham comparator
    Sham stimulation

    Sham stimulation via earlobe

    Device: Sham stimulation via earlobe

Interventions

  • DeviceVagus nerve stimulation via tragus

    The device will send stimulus intensity of around 0.5mA via tragus in the left ear (based on participants' subjective report), delivered with a pulse width of 0.5 ms at 25 Hz. Stimulation will be active for 30 seconds, followed by a break of 30 seconds.

  • DeviceSham stimulation via earlobe

    The device will send stimulus intensity of around 0.5mA via the earlobe in the left ear (based on participants' subjective reports), delivered with a pulse width of 0.5 ms at 25 Hz. Stimulation will be active for 30 seconds, followed by a break of 30 seconds.

06

What researchers measure

Primary outcomes

  1. The ability of inhibitory control in an emotional Go-Nogo task

    Analysis the behavioral and brain data recorded during the task

    Time frame: After 30 minutes stimulation

  2. Oxytocin release

    Investigating the oxytocin release after taVNS via tragus and earlobe based on saliva samples

    Time frame: within 5 minutes after taVNS via tragus and earlobe

07

Study locations

1 site
  • University of Electronic Science and Technology of China
    Chengdu, Sichuan 611731, China
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 13, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05468385
Responsible party
Keith Kendrick (Professor, University of Electronic Science and Technology of China) — Principal investigator
First posted
Jul 21, 2022
Start date
May 1, 2022
Primary completion
Jul 20, 2022
Completion
Aug 5, 2022
Last update
Dec 13, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion